Silica Nanodepletors: Targeting and Clearing Alzheimer's beta-Amyloid Plaques
- Silica Nanodepletors: Targeting and Clearing Alzheimer's beta-Amyloid Plaques
- 이준석; 이효진; 정희진; 정유정; Rsemarie Wilton; 이창헌; 이병일; 임진영; 최종호; 강현오; 이병두; Elena A. Rozhkova; 박찬범
- Issue Date
- Advanced functional materials
- VOL 30, NO 15, 1019475
- Abnormal accumulation of β-amyloid (Aβ) peptide aggregates in the brain is a major hallmark of Alzheimer’s disease (AD). Aβ aggregates interfere with neuronal communications, ultimately causing neuronal damage and brain atrophy. Much effort has been made to develop AD treatments that suppress Aβ aggregate formation, thereby attenuating Aβ-induced neurotoxicity. Here, the design of Aβ nanodepletors consisting of ultralarge mesoporous silica nanostructures and anti-Aβ single-chain variable fragments, with the goal of targeting and eliminating aggregative Aβ monomers, is reported. The Aβ nanodepletors impart a notable decline in Aβ aggregate formation, resulting in significant mitigation of Aβ-induced neurotoxicity in vitro. Furthermore, stereotaxic injections of Aβ nanodepletors into the brain of an AD mouse model system successfully suppress Aβ plaque formation in vivo up to ≈ 30%, suggesting that Aβ nanodepletors can serve as a promising antiamylodoisis material.
- Appears in Collections:
- KIST Publication > Article
- Files in This Item:
There are no files associated with this item.
- RIS (EndNote)
- XLS (Excel)
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.